APAC Pacemaker Market

APAC Pacemaker Market Size (2023 to 2028)

The pacemaker market in the APAC is estimated to value USD 1.46 billion by 2028 from USD 1.09 billion in 2023, growing at a CAGR of 6.01% from 2023 to 2028.

The growth in the APAC pacemaker market is increasing with considerable contributions from governments. In addition, there are many technological advancements in pacemaker equipment like MRI-safe pacemakers that are increasing the demand for pacemakers. These are helping in the growth of the APAC pacemaker market at a rapid rate.

The increase in cardiovascular diseases is significantly driving the market. Cardiovascular diseases require implantation of the pacemakers to enhance the outcome and help the patient. There are new advanced methods of implanting the pacemakers with minimally invasive techniques. Moreover, many new reimbursement methods have been introduced to help the patients and also easy payment methods.

The ordinary pacemaker may lead to a scar from the surgery and a lump on the skin, so to avoid this leadless pacemaker is introduced with which we can avoid having any of them. Wireless monitoring has also been introduced to easy monitoring of the patient. These are increasing the demand for the pacemaker market. With growing demand and new technologies, MRI-conditional models can be used for MR imaging treatments without changing the device's settings. In these recent years, many new methods and models have been introduced with a new application for pacemaker technology. 

The main drawbacks that hamper the pacemaker market's growth in the APAC region are the lack of awareness of the advantages of the pacemakers and the disadvantages of cardiovascular diseases in underdeveloped and developing countries. The cost of the treatment is also reducing the growth of the market. Problems with the equipment causing the return of the equipment are also hampering the development of the market. The infections on the skin due to the pacemaker and swelling near the pacemaker area are also some of the major restraints of the pacemakers.

This research report on the Asia Pacific pacemaker market has been segmented and sub-segmented into the following categories:

 By Product:

• Implantable
• External Pacemakers

By Application:

• Unipolar
• Bipolar Pacemakers

By Country:

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

Geographically, Asia Pacific is expected to grow quickly, with China and India leading the regional market. The number of new players is increasing, and investments from the key players are helping the research and development department find recent advancements and new opportunities in the market. Many countries are concentrating on developing new and creative methods in the diagnosis and treatment of cardiovascular diseases effectively. Due to support from the government, the market is expected to grow in the future. As the elderly population is increasing, the problems such as arrhythmias, heart failure are increasing. The factors such as the increasing number of obese people and people affected by diabetes are also growing rapidly. The problems caused by smoking are also increasing. The unhealthy lifestyle of the people is also affecting the market. These factors are helping the market to progress at a rapid rate in China. In China, the fatalities due to cardiovascular diseases are increasing. In China, the pacemaker market is growing due to the prevalence of cardiovascular diseases. The China government is also supporting the growth of the pacemaker market.

KEY MARKET PLAYERS:

Companies playing a leading role in the Asia Pacific pacemaker market profiled in this report are Medtronic, Sorin Group, Biotronik GmbH & Co. KG., Boston Scientific Corporation, Vitatron, St. Jude Medical, Inc., and Zoll Medical Corporation.